Galux

Galux provides molecular design technology focusing on discovering and developing novel drugs for incurable and rare diseases.

ActiveArtificial Intelligence (AI)BioTechMedicalProduct ResearchProfessional Services

Website LinkedIn

Updated: Feb 17, 2026 ·

About

Galux specializes in the field of biotechnology, focusing on the development of advanced drug discovery technologies. The company's core offering is GaluxDesign, a pioneering platform engineered for protein therapeutics design. This system uniquely combines artificial intelligence with established physical principles to enhance the drug development process.

Recent News & Mentions

Feb 9, 2026FundingGalux - Series B

Financial History

Galux has raised $29.0M across 1 funding round. Most recently, it raised $29.0M Series B in February 2026.

Total Raised

$29.0M

Valuation

N/A

Funding Rounds Raised

Date	Round	Lead Investors	Other Investors
Feb 9, 2026	$29.0M Series B	Dayli Partners, InterVest Co.	Korea Development Bank, Korea Investment & Securities, Mirae Asset Securities, NCore Ventures, Pathway Partners, SL Investment, Snickpick Investment, Yuanta Investment

Financial History

Galux has raised $29.0M across 1 funding round.

Total Raised

$29.0M

Valuation

N/A

Deep Dive

The GaluxDesign platform is designed to perform critical functions in molecular design. Its capabilities include protein structure prediction, protein-protein interaction prediction, and protein-ligand interaction prediction. These functionalities are integral to understanding and manipulating biological molecules at a fundamental level, which is crucial for creating effective new treatments.

Galux directs its efforts towards the discovery and development of novel drugs for specific therapeutic areas. The company places a particular emphasis on addressing incurable and rare diseases, aiming to provide solutions where current treatments may be limited or non-existent. This focus underscores a commitment to tackling significant unmet medical needs.

Through its innovative AI-based drug design and optimization platform, Galux seeks to accelerate the process of bringing new therapeutic options to patients. The integration of cutting-edge AI with biophysical understanding positions Galux as a contributor to the evolution of protein therapeutics.

Sources

Frequently Asked Questions

Which types of diseases does Galux primarily target with its drug development efforts?

Galux focuses on discovering and developing novel drugs specifically for incurable and rare diseases, addressing areas with significant unmet medical needs.

What specific predictions can Galux's platform make to aid in drug discovery?

The GaluxDesign platform is capable of performing protein structure prediction, protein-protein interaction prediction, and protein-ligand interaction prediction to advance drug development.